Rolf Alexander Janosi
Overview
Explore the profile of Rolf Alexander Janosi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
663
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hellhammer K, Schindhelm F, Riebisch M, Janosi R, Lind A, Totzeck M, et al.
Catheter Cardiovasc Interv
. 2025 Mar;
PMID: 40070322
Background: Mitral valve transcatheter edge-to-edge repair (M-TEER) is increasingly applied in patients with high surgical risk. We aimed to evaluate whether the PASCAL system can be applied in an all-comers...
2.
Pinsdorf D, Messiha D, Knuschke R, Petrikhovich O, Lortz J, Janosi R, et al.
Vasa
. 2025 Jan;
PMID: 39882734
Pulmonary embolism (PE) can result in high mortality. Early risk stratification and treatment are critical for individualized management. In patients with intermediate-high-risk (IHR) PE, guidelines recommend to consider a percutaneous...
3.
Abusharekh M, Kampf J, Dykun I, Backmann V, Janosi R, Totzeck M, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2024 Oct;
23:200336.
PMID: 39403572
Background: Smoking has conflicting results on outcomes following acute myocardial infarction (AMI). We evaluated the independent influence of smoking status on patient outcomes. Methods: We included patients with AMI undergoing...
4.
Jakstaite A, Vogel J, Luedike P, Janosi R, Carpinteiro A, Rischpler C, et al.
J Clin Med
. 2024 Feb;
13(3).
PMID: 38337363
Aims: The optimal strategy to identify transthyretin-type cardiac amyloidosis (ATTR-CA) in patients with aortic stenosis (AS) is still unclear. This study aimed to investigate if targeted screening for ATTR-CA in...
5.
Abusharekh M, Kampf J, Dykun I, Souri K, Backmann V, Al-Rashid F, et al.
Eur Heart J Qual Care Clin Outcomes
. 2024 Jan;
10(5):402-410.
PMID: 38192031
Background: Acute total occlusion (ATO) is diagnosed in a substantial proportion of patients with non-ST-elevation myocardial infarction (NSTEMI). We compared procedural outcomes and long-term mortality in patients with STEMI with...
6.
Alyaydin E, Janosi R, Luedike P, Rassaf T, Papathanasiou M
Am J Cardiol
. 2023 Jun;
201:116-122.
PMID: 37356375
Alcohol septal ablation is an established treatment for selected patients with hypertrophic cardiomyopathy and left ventricular outflow tract obstruction (LVOT). The safety and efficacy of septal microsphere embolization (SME) have...
7.
Lind A, Ahsan M, Totzeck M, Al-Rashid F, Haddad A, Dubler S, et al.
Int J Cardiol
. 2023 Jun;
387:131130.
PMID: 37355243
Background: A minimal approach, using local anaesthesia alone, has been advocated to promote faster transcatheter aortic valve replacement (TAVR) procedures in intermediate-risk patients. Pre- and periprocedural anxiety and pain remain...
8.
Czerny M, Gross-Fengels W, Harloff A, Janosi R, Kolbel T, Mahnken A, et al.
Thorac Cardiovasc Surg
. 2023 May;
71(S 03):S107-S136.
PMID: 37220772
No abstract available.
9.
Alyaydin E, Vogel J, Luedike P, Rassaf T, Janosi R, Papathanasiou M
J Clin Med
. 2023 Apr;
12(8).
PMID: 37109359
(1) Background: The transcoronary ablation of septal hypertrophy (TASH) is an established therapy for hypertrophic obstructive cardiomyopathy (HOCM). Previous studies on this topic are characterised by a consistent male predominance...
10.
Mohajeri D, Rammos C, Tsagakis K, Schlosser T, Ruhparwar A, Rassaf T, et al.
Life (Basel)
. 2023 Mar;
13(3).
PMID: 36984006
Chronic type B aortic dissection (cTBAD) is a rare but challenging condition that requires individual treatment strategies. Especially the long-term therapy impacts prognosis. In this single-center retrospective study, we evaluated...